Piperazine derivatives useful for the treatment of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 409/04 (2006.01) A61K 31/381 (2006.01) A61K 31/4015 (2006.01) A61K 31/4439 (2006.01) C07D 207/24 (2006.01) C07D 295/02 (2006.01) C07D 333/08 (2006.01) C07D 333/10 (2006.01)

Patent

CA 2575359

The invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Ra, Rb, Rc, Rd, Re, Rf and Y are as defined in the specification. The compounds are partial or full agonists at the growth hormone secretagogue (GHS) receptors . Pharmaceutical compositions comprising the compounds, methods of preparing the compounds, uses of the compounds and methods involving the compounds are also provided.

Cette invention concerne des composés représentés par la formule (I) ou des sels de ces composés pharmaceutiquement acceptables. Dans cette formule, Ra, Rb, Rc, Rd, Re, Rf et Y sont comme définis dans le descriptif. Ces composés sont des agonistes partiels ou complets des récepteurs du sécrétagogue de l'hormone de croissance (GHS). L'invention concerne également des compositions contenant ces composés, des méthodes de fabrication desdits composés, leur utilisation et leurs modalités d'utilisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazine derivatives useful for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives useful for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives useful for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1404714

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.